Navigation Links
Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S.
Date:10/4/2011

REDMOND, Wash., Oct. 4, 2011 /PRNewswire/ -- Fukuda Denshi USA has announced the introduction of the company's new UF-760AG ultrasound system in the United States. The color portable ultrasound unit provides outstanding imaging quality in a compact system and is designed for diagnostic use in numerous specialty markets.

"The UF-760AG unit is extremely versatile, offering advanced imaging technologies to improve diagnostic confidence," said Ray Usukura, President Fukuda Denshi USA, "The system is highly suited for a wide array of clinical applications including , cardiac (adult and pediatric), peripheral vascular, abdominal, pediatric, small organ, neonatal/adult cephalic, transcranial,  breast, musculo-skeletal and obstetrics and gynecology exams."

"Many of the features offered on the UF-760AG system are only found on premium ultrasound systems.  These include 3D / 4D, CW Doppler, PW Doppler, Color Doppler, stress echo, spatial compounding, speckle reduction, tissue harmonic and tissue specific imaging. However the UF760AG is the only portable system offering two probe connectors for maximum user comfort and flexibility"

"The UF-760AG is lightweight and designed for use in any location," said Usukura.  "The system has an on-board imaging archive for more than 150,000 still images. With a 15-inch matrix (TFT) LCD flat monitor, the battery life is approximately 1 hour. As with all of our products this ultrasound unit will provide our customers with the greatest economic and clinical value while offering the image and product quality that customers would expect from Fukuda Denshi."

"Fukuda Denshi strives to contribute to global medical progress through design and development on innovative medical equipment" said Usukura.  "The UF-760AG system's architecture is designed to accommodate future upgrades as imaging technology advances, which will provide tremendous economic value for any clinical practice."

For US customer and distribution inquires please contact:

Loran Van Noy
Fukuda Denshi USA
17725-C NE 65th Street
Redmond, WA 98052
Phone: 425-881-7737
lvannoy@fukuda.com
www.fukuda.com

Current US Distributors:

DMS Topline Medical
Fargo, ND 58102
877-986-7633

STC Medical
Orlando, Florida
352-342-3787

Core Ultrasound
Comstock Park, MI
616-785-2673

The Imaging Specialist Group
Miami, FL
305-591-8888


'/>"/>
SOURCE Fukuda Denshi USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
2. Volcano Announces It Will End Distribution Agreement with Fukuda; Transition Enhances Companys Direct Selling Program in Japan
3. Waters Introduces New TruView LCMS Certified Vials for the Analytical Laboratory
4. BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
5. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
6. Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves
7. Sensitech Inc. Introduces Temperature and Humidity Monitor for Flammable and Hazardous Environments
8. IntelligentMDx (IMDx) Introduces a CE-Marked Automated Molecular Test for the Detection of Vancomycin Resistance Genes vanA and vanB Most Commonly Found in Vancomycin-Resistant Enterococci
9. CPhI Conferences Introduces New Lunchtime Education Series
10. Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer
11. Mindray Introduces DP-50 Portable Ultrasound System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):